M. Wakabayashi

Hypercomplementemia in adult patients with IgA nephropathy

T. Fujita, Y. Tomino, S. Horikoshi, 2007, Journal of clinical laboratory analysis.

Efficacy of adsorbent in delaying dialysis initiation among chronic kidney disease patients

Y. Tomino, S. Horikoshi, C. Hamada, 2011 .

Glomerular changes in the KK‐Ay/Ta mouse: A possible model for human type 2 diabetic nephropathy

Y. Tomino, K. Funabiki, T. Gohda, 2006, Nephrology.

Long-Term Effects of the Oral Adsorbent, AST-120, in Patients with Chronic Renal Failure

Y. Tomino, T. Hayashi, S. Horikoshi, 2009, The Journal of international medical research.

Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function

T. Fujita, Y. Tomino, S. Horikoshi, 2011, BMC nephrology.

Serum Concentration of Complement Components of the Lectin Pathway in Maintenance Hemodialysis Patients, and Relatively Higher Levels of L‐Ficolin and MASP‐2 in Mannose‐Binding Lectin Deficiency

M. Matsushita, Y. Tomino, S. Horikoshi, 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia--changes in serum potassium levels with or without a RAAS inhibitor.

Y. Tomino, S. Horikoshi, T. Nishitani, 2007, Clinical nephrology.

Acquired Loss of Erythrocyte Complement Receptor Type 1 in Patients with Diabetic Nephropathy Undergoing Hemodialysis

T. Fujita, Y. Tomino, Kisara Onda, 2006, Nephron Experimental Nephrology.